ISRCTN ISRCTN63230740
DOI https://doi.org/10.1186/ISRCTN63230740
Secondary identifying numbers 7925
Submission date
29/04/2010
Registration date
29/04/2010
Last edited
25/07/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Phil Hopkins
Scientific

Beckett Street
Leeds
LS9 7TF
United Kingdom

Study information

Study designNon-randomised interventional trial
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeNot Specified
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleWhat is the ED95 dose for bupivacaine for supraclavicular brachial plexus block using ultrasound?
Study objectivesTo determine the ED95 dose for 0.5% bupivacaine for supraclavicular brachial plexus block using ultrasound.
Ethics approval(s)Leeds (East) Research Ethics Committee approved on the 2nd November 2009 (ref: 09/H1306/98). Amendment approved on the 22nd February 2010.
Health condition(s) or problem(s) studiedTopic: Generic Health Relevance and Cross Cutting Themes; Subtopic: Generic Health Relevance (all Subtopics); Disease: Anaesthetics
InterventionPrimary outcome is the success or failure of the supraclavicular block. This will be assessed by testing the patient's ability to detect cold sensation by application of a cold alcohol swab to the skin. This will be measured by asking the patient to score the cold sensation from 0 - 10. Any score higher than 0 will be deemed an unsuccessful block. This assessment will be carried out at 15 minute intervals for upto 45 minutes after the block has been performed. There will be no follow up after this.
Intervention typeProcedure/Surgery
Primary outcome measureAbility to detect cold sensation by application of cold alcohol swab to the skin at the sensory dermatomes of the median, ulnar, radial and musculocutaneous nerves in the upper limb, measured 45 minutes after performing the supraclavicular block.
Secondary outcome measuresNo secondary outcome measures
Overall study start date05/10/2009
Completion date04/10/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned Sample Size: 40
Key inclusion criteria1. American Society of Anaesthesiologists (ASA) 1 - 3 patients
2. Aged greater than 18 years, either sex
3. Routine hand, forearm or upper limb surgery
Key exclusion criteria1. ASA greater than 3
2. Aged less than 18 years
3. Allergy to bupivacaine
4. Unable to give written informed consent
5. Body Mass Index greater than 35 kg/m^2
6. Pregnant women
Date of first enrolment05/10/2009
Date of final enrolment04/10/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Beckett Street
Leeds
LS9 7TF
United Kingdom

Sponsor information

University of Leeds (UK)
University/education

Academic Department of Rehabilition Medicine
Woodhouse Lane
Leeds
LS2 9JT
England
United Kingdom

Email neville.young@leedsth.nhs.uk
Website http://www.leeds.ac.uk/
ROR logo "ROR" https://ror.org/024mrxd33

Funders

Funder type

Government

National Institute for Academic Anaesthesia (UK)
Private sector organisation / Universities (academic only)
Alternative name(s)
NIAA
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2013 Yes No
HRA research summary 28/06/2023 No No